Atlas Trials

Correlation Between CYP2C19 Genotype, Level Of Clopidogrel Metabolite And Platelet Inhibition Status

Clinical trial NCT01210248 · UNKNOWN

Trial details

NCT number
NCT01210248
Sponsor
Assaf-Harofeh Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
PRIMARY FOCUS:PATIENT THAT TAKE CLOPIDOGREL
Start date
2010-09-01
Primary completion
2012-01-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.